|
61 |
Bioequivalence Studies of New Generic Formulations of Vildagliptin and Fixed-Drug Combination of Vildagliptin and Metformin Versus Respective Originator Products in Healthy Volunteers
Enthalten in Diabetes therapy Bd. 13, 11.5.2022, Nr. 6, date:6.2022: 1215-1229
|
|
|
|
62 |
Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Versus Originator Insulin Aspart Mix 70/30 (NovoMix 30) in People with Diabetes: A 26-Week, Randomized, Open-Label Trial (GEMELLI M)
Enthalten in Diabetes therapy Bd. 13, 14.4.2022, Nr. 5, date:5.2022: 1053-1071
|
|
|
|
63 |
ChemInform Abstract: A Case for August Wilhelm Hofmann as the Originator of the Field of Organophosphorus Chemistry
Enthalten in ChemInform Bd. 44, 2013, Nr. 38: no-no. 1 S.
|
|
|
|
64 |
Cleft lip: The historical perspective
Enthalten in Indian journal of plastic surgery Bd. 42, 2009, Nr. S 01, 01: S4-S8
|
|
|
|
65 |
Comparability of Biosimilar Filgrastim with Originator Filgrastim: Protein Characterization, Pharmacodynamics, and Pharmacokinetics
Enthalten in BioDrugs Bd. 29, 3.4.2015, Nr. 2, date:4.2015: 123-131
|
|
|
|
66 |
Comparative Efficacy and Safety of Biosimilar Rituximab and Originator Rituximab in Rheumatoid Arthritis and Non-Hodgkin’s Lymphoma: A Systematic Review and Meta-analysis
Enthalten in BioDrugs Bd. 33, 24.8.2019, Nr. 5, date:10.2019: 469-483
|
|
|
|
67 |
Comparative Safety of Originator and Biosimilar Epoetin Alfa Drugs: An Observational Prospective Multicenter Study
Enthalten in BioDrugs Bd. 32, 20.7.2018, Nr. 4, date:8.2018: 367-375
|
|
|
|
68 |
Comparison of originator and biosimilar monoclonal antibodies using HRMS, Fc affinity chromatography, and 2D-HPLC
Enthalten in Analytical and bioanalytical chemistry Bd. 414, 27.7.2022, Nr. 23, date:9.2022: 6761-6769
|
|
|
|
69 |
Correction to: Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018
Enthalten in Advances in therapy Bd. 39, 30.8.2022, Nr. 11, date:11.2022: 5300
|
|
|
|
70 |
Correction to: The Frequency of Ovarian Hyperstimulation Syndrome and Thromboembolism with Originator Recombinant Human Follitropin Alfa (GONAL-f) for Medically Assisted Reproduction: A Systematic Review
Enthalten in Advances in therapy Bd. 38, 19.7.2021, Nr. 8, date:8.2021: 4602
|
|
Administration
